These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
488 related articles for article (PubMed ID: 31259484)
1. N-terminal pro brain natriuretic peptide eliminates the prognostic effect of atrial fibrillation in patients with chronic heart failure. Schnorbach J; Fröhlich H; Täger T; Corletto A; Katus HA; Frankenstein L ESC Heart Fail; 2019 Aug; 6(4):640-648. PubMed ID: 31259484 [TBL] [Abstract][Full Text] [Related]
2. Natriuretic peptides in patients with atrial fibrillation and advanced chronic heart failure: determinants and prognostic value of (NT-)ANP and (NT-pro)BNP. Rienstra M; Van Gelder IC; Van den Berg MP; Boomsma F; Van Veldhuisen DJ Europace; 2006 Jul; 8(7):482-7. PubMed ID: 16798760 [TBL] [Abstract][Full Text] [Related]
3. Direct comparison of mid-regional pro-atrial natriuretic peptide with N-terminal pro B-type natriuretic peptide in the diagnosis of patients with atrial fibrillation and dyspnoea. Eckstein J; Potocki M; Murray K; Breidthardt T; Ziller R; Mosimann T; Klima T; Hoeller R; Moehring B; Sou SM; Rubini Gimenez M; Morgenthaler NG; Mueller C Heart; 2012 Oct; 98(20):1518-22. PubMed ID: 22865868 [TBL] [Abstract][Full Text] [Related]
4. Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide Levels in Heart Failure Patients With and Without Atrial Fibrillation. Kristensen SL; Jhund PS; Mogensen UM; Rørth R; Abraham WT; Desai A; Dickstein K; Rouleau JL; Zile MR; Swedberg K; Packer M; Solomon SD; Køber L; McMurray JJV; Circ Heart Fail; 2017 Oct; 10(10):. PubMed ID: 29018174 [TBL] [Abstract][Full Text] [Related]
5. Effect of atrial fibrillation on plasma NT-proBNP in chronic heart failure. Corell P; Gustafsson F; Kistorp C; Madsen LH; Schou M; Hildebrandt P Int J Cardiol; 2007 May; 117(3):395-402. PubMed ID: 16919342 [TBL] [Abstract][Full Text] [Related]
6. Atrial fibrillation and amino-terminal pro-brain natriuretic peptide as independent predictors of prognosis in systolic heart failure. Dini FL; Gabutti A; Passino C; Fontanive P; Emdin M; De Tommasi SM Int J Cardiol; 2010 Apr; 140(3):344-50. PubMed ID: 19128846 [TBL] [Abstract][Full Text] [Related]
7. Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction. Rørth R; Jhund PS; Yilmaz MB; Kristensen SL; Welsh P; Desai AS; Køber L; Prescott MF; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Packer M; McMurray JJV Circ Heart Fail; 2020 Feb; 13(2):e006541. PubMed ID: 32065760 [TBL] [Abstract][Full Text] [Related]
8. N-Terminal Pro-B-Type Natriuretic Peptide Levels for Risk Prediction in Patients With Heart Failure and Preserved Ejection Fraction According to Atrial Fibrillation Status. Kristensen SL; Mogensen UM; Jhund PS; Rørth R; Anand IS; Carson PE; Desai AS; Pitt B; Pfeffer MA; Solomon SD; Zile MR; Køber L; McMurray JJV Circ Heart Fail; 2019 Mar; 12(3):e005766. PubMed ID: 30871349 [TBL] [Abstract][Full Text] [Related]
9. [Changes in NT-proBNP levels in patients with atrial fibrillation related to heart failure]. Pokorná V; Jurkovicová O; Kaluzay J; Stecová A; Pont'uch P Vnitr Lek; 2010 Aug; 56(8):788-94. PubMed ID: 20845610 [TBL] [Abstract][Full Text] [Related]
10. Clinical and echocardiographic characteristics of individuals aged 75/76 years old with screening-detected elevated NT-proBNP levels. Al-Khalili F; Kemp-Gudmundsdottir K; Svennberg E; Fredriksson T; Frykman V; Friberg L; Rosenqvist M; Engdahl J Open Heart; 2020; 7(1):e001200. PubMed ID: 32153793 [TBL] [Abstract][Full Text] [Related]
11. N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation). Hijazi Z; Wallentin L; Siegbahn A; Andersson U; Christersson C; Ezekowitz J; Gersh BJ; Hanna M; Hohnloser S; Horowitz J; Huber K; Hylek EM; Lopes RD; McMurray JJ; Granger CB J Am Coll Cardiol; 2013 Jun; 61(22):2274-84. PubMed ID: 23563134 [TBL] [Abstract][Full Text] [Related]
12. N-terminal pro-brain natriuretic peptide levels had an independent and added ability in the evaluation of all-cause mortality in older Chinese patients with atrial fibrillation. Fu S; Jiao J; Guo Y; Zhu B; Luo L BMC Geriatr; 2019 Feb; 19(1):56. PubMed ID: 30819103 [TBL] [Abstract][Full Text] [Related]
13. The diagnostic utility of N-terminal pro-B-type natriuretic peptide for the detection of major structural heart disease in patients with atrial fibrillation. Shelton RJ; Clark AL; Goode K; Rigby AS; Cleland JG Eur Heart J; 2006 Oct; 27(19):2353-61. PubMed ID: 16952921 [TBL] [Abstract][Full Text] [Related]
14. Prognostic Value of Serum N-Terminal Pro-Brain Natriuretic Peptide Level over Heart Failure for Stroke Events and Deaths in Patients with Atrial Fibrillation. Kuronuma K; Okumura Y; Morikawa T; Yokoyama K; Matsumoto N; Tachibana E; Oiwa K; Matsumoto M; Kojima T; Haruta H; Nomoto K; Sonoda K; Arima K; Kogawa R; Takahashi F; Kotani T; Ohkubo K; Fukushima S; Itou S; Kondo K; Chiku M; Ohno Y; Onikura M; Hirayama A; Int Heart J; 2020 May; 61(3):492-502. PubMed ID: 32418966 [TBL] [Abstract][Full Text] [Related]
15. Association of atrial fibrillation and amino-terminal pro-brain natriuretic peptide concentrations in dyspneic subjects with and without acute heart failure: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study. Morello A; Lloyd-Jones DM; Chae CU; van Kimmenade RR; Chen AC; Baggish AL; O'Donoghue M; Lee-Lewandrowski E; Januzzi JL Am Heart J; 2007 Jan; 153(1):90-7. PubMed ID: 17174644 [TBL] [Abstract][Full Text] [Related]
16. The prognostic value of individual NT-proBNP values in chronic heart failure does not change with advancing age. Frankenstein L; Clark AL; Goode K; Ingle L; Remppis A; Schellberg D; Grabs F; Nelles M; Cleland JG; Katus HA; Zugck C Heart; 2009 May; 95(10):825-9. PubMed ID: 19147626 [TBL] [Abstract][Full Text] [Related]
17. The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure. Santema BT; Chan MMY; Tromp J; Dokter M; van der Wal HH; Emmens JE; Takens J; Samani NJ; Ng LL; Lang CC; van der Meer P; Ter Maaten JM; Damman K; Dickstein K; Cleland JG; Zannad F; Anker SD; Metra M; van der Harst P; de Boer RA; van Veldhuisen DJ; Rienstra M; Lam CSP; Voors AA Clin Res Cardiol; 2020 Mar; 109(3):331-338. PubMed ID: 31263996 [TBL] [Abstract][Full Text] [Related]
18. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure. von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563 [TBL] [Abstract][Full Text] [Related]
20. Atrial fibrillation is an independent determinant of increased NT-proBNP levels in outpatients with signs and symptoms of heart failure. Jug B; Sebestjen M; Sabovic M; Pohar M; Keber I Wien Klin Wochenschr; 2009; 121(21-22):700-6. PubMed ID: 19998011 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]